ask="0.1675"
ask_size="1000"
average_daily_volume="4008680"
bid="0.1601"
bid_size="5000"
book_value="0.1040"
change="-0.0026"
change_from_200_day_moving_average="-0.0546"
change_from_50_day_moving_average="-0.0183"
change_from_52_week_high="-0.4746"
change_From_52_week_low="0.0103"
change_in_percent="-1.5476%"
close="0.1654"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.9020"
ebitda="-16.86M"
eps_estimate_current_year="-0.6200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="0.1700"
ex_dividend_date="N/A"
float_shares="125385000"
high="0.1750"
high_52_weeks="0.6400"
last_trade_date="3/13/2017"
last_trade_price="0.1654"
last_trade_size="191"
last_trade_time="4:00pm"
low="0.1610"
low_52_weeks="0.1551"
market_capitalization="21.72M"
moving_average_200_day="0.2200"
moving_average_50_day="0.1837"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="3.0000"
open="0.1750"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-24.8182%"
percent_change_from_50_day_moving_average="-9.9688%"
percent_change_from_52_week_high="-74.1562%"
percent_change_from_52_week_low="+6.6409%"
previous_close="0.1680"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.6154"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="2.9800"
stock_exchange="NCM"
symbol="IMNP"
volume="2224639"
weeks_range_52="0.1551 - 0.6400"
